Research Digest

You can also join our community and choose to have the Research Digest delivered straight to your inbox every month on a Friday afternoon by signing up to our mailing list here.

We appreciate the support of everyone who reads the Research Digest – we encourage regular subscribers to support us with a suggested donation of $2. You can donate here.

Research Digest 27/4/23

Welcome to the 94th edition of the Research Digest. This month’s edition summarises research studies investigating the impact of exercise on post-exertional malaise, offering invaluable insights into exercise pathophysiology for both ME/CFS and Long COVID. This month’s edition also highlights the long-awaited report from the parliamentary inquiry into Long COVID, which includes a recommendation for

Research Digest 30/3/23

Welcome to the 93rd edition of the Research Digest. This month’s edition summarises research that investigates factors that influence the prognosis of ME/CFS and demonstrates that high muscle sodium content, maybe a contributing factor to the pathophysiology of ME/CFS. A review is also highlighted that conveys what is presently known about Long COVID

Research Digest 23/2/23

Welcome to the 92nd edition of the Research Digest. This month recapitulates research studies that extend our understanding of ME/CFS and Long COVID. The effect of exercise on the content of extracellular vesicles is investigated for ME/CFS and for Long COVID symptoms. This edition also highlights comments made by Professor Brendan Crabb, CEO of the

Research Digest 22/12/22

Welcome to the 91st edition of the Research Digest.  In our final edition for the year, a study evaluating aspects of the current IOM criteria is presented, as well as national and international research findings concerning Long Covid.   The final edition also puts a spotlight on the disbelief that people living with invisible disabilities like

Research Digest 01/12/22

Welcome to the 90th edition of the Research Digest. This month’s edition features ME/CFS studies investigating microclotting and antibody targeting of gut bacteria. Also presented, is the study of serum samples from post-covid syndrome and -/+ME/CFS patients, to further study endothelial dysfunction and the role of angiogenesis in both study groups. And finally,

Research Digest 27/10/22

Welcome to the 89th edition of the Research Digest. This edition features a study looking more closely at blood cells to investigate mitochondrial abnormalities and immunological changes in ME/CFS. Furthermore, the effect of whole-body cryotherapy and activity monitoring in patients living with ME/CFS is presented. A link to Anne Wilson’s (Emerge Australia’s CEO) interview,

Research Digest 29/09/22

Welcome to the 88th edition of the Research Digest. This edition features a study that aimed to determine the value of a simple, objective office-based test in the evaluation of OI and brain fog and large genetic association study that sought to identify chromosomal regions that may be linked to ME/CFS.

Research Digest 25/08/22

Welcome to the 87th edition of the Research Digest. This month’s edition highlights emerging evidence of endothelial dysfunction, to further demonstrate the striking similarities of Long Covid to ME/CFS. The metabolism of tryptophan and the role of its metabolites are also presented and postulated to influence symptoms of ME/CFS, as well as suggested mechanisms

Research Digest 28/07/22

Welcome to the 86th edition of the Research Digest. This edition reviews research articles looking further into infectious mononucleosis and its links with ME/CFS and the impact of ME/CFS, on the quality of life for patients and their partners.  The digest also presents a recent ME/CFS brain imaging study that may prove useful diagnostically in

Research Digest 30/06/22

Welcome to the 85th edition of Emerge Australia’s Research Digest. As a special edition, this month’s digest recapitulates Emerge Australia’s ME/CFS Awareness Week Research Panel webinar, providing insight into how our local ME/CFS community is contributing to ME/CFS research in Australia; via their contributions to the ME/CFS Biobank and You+ME Registry Australia.

Research Digest 26/05/22

Welcome to the Research Digest’s 84th edition. This month we recap research studies of ME/CFS endothelial cell dysfunction and how metabolomics may provide insight into ME/CFS, pre-and post-exercise. Also presented, is advice for the treatment of Long Covid patients, given the injustices experienced by those with ME/CFS and a very honest account of what

Research Digest 28/04/22

Welcome to the 83rd edition of the Research Digest. This month’s edition features ME/CFS studies focused on orthostatic intolerance, the effects of Naltrexone on ME/CFS NK cells, as well as a promising ME/CFS eye movement diagnostic tool. This edition also highlights Emerge Australia’s radio interviews featuring Anne Wilson, our CEO campaigning for an update to

Research Digest 24/03/22

Welcome to the 82nd edition of the Research Digest. This month’s edition features studies investigating blood flow abnormalities that may contribute to the pathogenesis of ME/CFS and how lessons learnt from heat stroke may be useful to better understand ME/CFS. Further analysis of Long Covid and its overlap with ME/CFS symptomology is also presented with

Research Digest 24/02/22

Welcome to the 81st edition of the Research Digest. This edition reviews research articles investigating the potential of the cortical autonomic network, to act as a therapeutic target for ME/CFS symptom management, the involvement of C1q in ME/CFS pathology and more evidence demonstrating a linkage between ME/CFS and Long Covid. The highlights from a radio

Research Digest 23/12/21

Welcome to the 80th edition of the Research Digest. This edition summarises research papers trialling CT38s to investigate the involvement of the corticotropin-releasing factor system in ME/CFS and an Australian study observing the impact of life stressors, on those living with ME/CFS. The 80th and final edition of the research digest is concluded

Scroll to Top